Induced pluripotent stem cells have great therapeutic potential. But genomic and epigenomic analyses of these cells generated using current technology reveal abnormalities that may affect their safe use. See Articles p.58, p.63 & p.68
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hussein, S. M. et al. Nature 471, 58–62 (2011).
Gore, A. et al. Nature 471, 63–67 (2011).
Lister, R. et al. Nature 471, 68–73 (2011).
Mayshar, Y. et al. Cell Stem Cell 7, 521–531 (2010).
Laurent, L. C. et al. Cell Stem Cell 8, 106–118 (2011).
Baker, D. E. C. et al. Nature Biotechnol. 25, 207–215 (2007).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pera, M. The dark side of induced pluripotency. Nature 471, 46–47 (2011). https://doi.org/10.1038/471046a
Published:
Issue Date:
DOI: https://doi.org/10.1038/471046a